The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.

about

The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.

Item

http://www.wikidata.org/entity/Q55313663

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The cost-effectiveness and bud ...... ent of HIV infection in India.

@en

The cost-effectiveness and bud ...... ent of HIV infection in India.

@nl

type

Item

label

The cost-effectiveness and bud ...... ent of HIV infection in India.

@en

The cost-effectiveness and bud ...... ent of HIV infection in India.

@nl

prefLabel

The cost-effectiveness and bud ...... ent of HIV infection in India.

@en

The cost-effectiveness and bud ...... ent of HIV infection in India.

@nl

P1476

The cost-effectiveness and bud ...... ent of HIV infection in India.

@en

P2093

A David Paltiel

http://www.w3.org/2001/XMLSchema#string

Amy Zheng

http://www.w3.org/2001/XMLSchema#string

Bharat B Rewari

http://www.w3.org/2001/XMLSchema#string

Mingshu Huang

http://www.w3.org/2001/XMLSchema#string

Rochelle P Walensky

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials.

Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India

Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'Ivoire

Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.

Outcome of patients on second line antiretroviral therapy under programmatic condition in India

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada.

Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial.

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy

The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.

P304

e25085

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JIA2.25085

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth Mayer

Nagalingeswaran Kumarasamy

Kenneth A Freedberg

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29603882

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

5878415

http://www.w3.org/2001/XMLSchema#string